Advertisement

Coronaviruses pp 425-430 | Cite as

On the Role of Different Lymphocyte Subpopulations in the Course of Coronavirus MHV IV (JHM)-Induced Encephalitis in Lewis Rats

  • S. Schwender
  • A. Hein
  • H. Imrich
  • R. Dörries
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 342)

Abstract

The neurotropic strain of the mouse hepatitis virus (MHV), MHV-IV or JHM virus, causes neurological disorders in rats and mice when given intracerebrally 1,2. Depending on the rat strain and the age of the infected animal different courses of disease have been observed. Up to 2 weeks post partum Lewis (LEW) rats develop an acute fatal encephalitis, whereas animals older than 3 weeks usually do not succumb to the infection 3 but suffer from a subacute paralytic disease accompanied by multiple neurological disorders. However, the majority of them recovers completely roughly 3 weeks past infection 4. Since rats are expected to he immunologically competent at the age of 3 weeks, it is conceivable that maturity of the immune system probably plays a major role in the clinical course of the infection. We have recently shown, that T- and B-lymphocytes infiltrate into the central nervous system of these rats 4 and that the humoral immune response most likely contributes significantly to convalescence 5.

Keywords

Humoral Immune Response Lymphocyte Subset Infectious Virus Mouse Hepatitis Virus Immunize Spleen Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    F.S. Cheever, J.B. Daniels, A.M. Pappenheimer, & O.T. Bailey, J. Exp. Med., 90:181 (1949)PubMedCrossRefGoogle Scholar
  2. 2.
    K. Nagashima, H. Wege, R. Meyermann, & V. ter Meulen, Acta Neuropath., (Berl), 44:63 (1978)PubMedCrossRefGoogle Scholar
  3. 3.
    H. Wege, S. Siddell, & V. ter Meulen, in: “Current Topics in Microbiology and Immunology”, 99, M. Cooper, ed., Springer, (1982)Google Scholar
  4. 4.
    R. Dörries, S. Schwender, H. Imrich, & H. Harms, Immunology, 74:539 (1991)PubMedGoogle Scholar
  5. 5.
    S. Schwender, H. Imrich & R. Dörries, Immunology, 74:533 (1991)PubMedGoogle Scholar
  6. 6.
    N. Hirano, K. Fujiwara, S. Hino, & N. Matsumoto, Arch. Ges. Virusforsch., 44:298 (1974)PubMedCrossRefGoogle Scholar
  7. 7.
    J.O. Fleming, F.I. Wang, M.D. Trousdale, D.R. Hinton, & S.A. Stohlman, in: “Coronaviruses and Their Diseases”,D. Cavanagh and T.D.K. Brown, eds, Plenum Press, New York (1990)Google Scholar
  8. 8.
    P.T. Massa, R. Dörries, & V. ter Meulen, Nature, 320:543 (1986)PubMedCrossRefGoogle Scholar
  9. 9.
    J.A. Richt, & L. Stitz, Arch. Virol., 124:95 (1992)PubMedCrossRefGoogle Scholar
  10. 10.
    J.D. Sedgwick, S. Schwender, R. Gregerson, R. Dörries, & V. ter Meulen, J. Exp. Med., Submitted for publication Sept 1991Google Scholar
  11. 11.
    C.A. Colton, J. Yao, J.E. Keti, and D. Gilbert, J. Neuroimrnunol., 30:89 (1992)CrossRefGoogle Scholar
  12. 12.
    R.A. Shuhin, M.A. Sussmann, J.O. Fleming, & S.A. Stohlman, Microb. Pathog., 8:305 (1990)CrossRefGoogle Scholar
  13. 13.
    S. Perlman, R. Schelper, E. Bolger, & D. Ries, Microb. Pathog 2:185 (1987)PubMedCrossRefGoogle Scholar
  14. 14.
    C.P. Rossi, E. Cash, C. Aubert, and A. Coutinho, J. Virol., 65:3895 (1991)PubMedGoogle Scholar
  15. 15.
    F. Zimprich, J. Winter, H. Wege, H. Lassmann, Neuropathol. Appl. Neurobiol. 17:469 (1991)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • S. Schwender
    • 1
  • A. Hein
    • 1
  • H. Imrich
    • 1
  • R. Dörries
    • 1
  1. 1.Institut für Virologie und ImmunbiologieUniversität WürzburgWürzburgGermany

Personalised recommendations